These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2004471)

  • 21. Physiopathology of the renin-angiotensin system in the ovary.
    De Nuccio I; Salvati G; Genovesi G; Paolini P; Marcellini L; Schiavello V; Re M
    Minerva Endocrinol; 1999 Jun; 24(2):77-81. PubMed ID: 10941427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying renin-angiotensin-aldosterone system suppression.
    Verdonk K; Saleh L; Lankhorst S; Smilde JE; van Ingen MM; Garrelds IM; Friesema EC; Russcher H; van den Meiracker AH; Visser W; Danser AH
    Hypertension; 2015 Jun; 65(6):1316-23. PubMed ID: 25870197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased concentrations of renin, aldosterone and Ca125 in a case of spontaneous, recurrent, familial, severe ovarian hyperstimulation syndrome.
    Di Carlo C; Bruno P; Cirillo D; Morgera R; Pellicano M; Nappi C
    Hum Reprod; 1997 Oct; 12(10):2115-7. PubMed ID: 9402264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy.
    Sealey JE; Itskovitz-Eldor J; Rubattu S; James GD; August P; Thaler I; Levron J; Laragh JH
    J Clin Endocrinol Metab; 1994 Jul; 79(1):258-64. PubMed ID: 8027239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the human ovarian renin-angiotensin system: optimization of assay methodology and effects of follicular stimulants.
    Brameld JM; Broughton Pipkin F; Symonds EM
    J Endocrinol; 1990 Dec; 127(3):513-21. PubMed ID: 2126277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ovarian renin-angiotensin system: renin-like activity and angiotensin II/III immunoreactivity in gonadotropin-stimulated and unstimulated human follicular fluid.
    Lightman A; Tarlatzis BC; Rzasa PJ; Culler MD; Caride VJ; Negro-Vilar AF; Lennard D; DeCherney AH; Naftolin F
    Am J Obstet Gynecol; 1987 Apr; 156(4):808-16. PubMed ID: 3107387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Menotropin with HCG in ovulation induction. Results in 56 patients including a case of severe ovarian hyperstimulation.
    Roland M
    Fertil Steril; 1969; 20(6):1004-16. PubMed ID: 5361457
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ovarian hyperstimulation syndrome and its therapy].
    Presl J
    Cesk Gynekol; 1980 Sep; 45(8):603-6. PubMed ID: 7428086
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma prorenin response to human chorionic gonadotropin in ovarian-hyperstimulated women: correlation with the number of ovarian follicles and steroid hormone concentrations.
    Itskovitz J; Sealey JE; Glorioso N; Rosenwaks Z
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7285-9. PubMed ID: 3118364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Features of the Renin-angiotensin system in ascites and pleural effusion during severe ovarian hyperstimulation syndrome.
    Delbaere A; Bergmann PJ; Englert Y
    J Assist Reprod Genet; 1997 May; 14(5):241-4. PubMed ID: 9147235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndrome.
    Jäger W; Diedrich K; Wildt L
    Fertil Steril; 1987 Oct; 48(4):675-8. PubMed ID: 3115839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Massive hyperstimulation and borderline carcinoma of the ovary. A possible association.
    Atlas M; Menczer J
    Acta Obstet Gynecol Scand; 1982; 61(3):261-3. PubMed ID: 7124357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of severe ovarian hyperstimulation syndrome after gonadotropin therapy.
    Moneta E; Garcea N; Scirpa P; Mango D
    Folia Endocrinol; 1974 Oct; 27(5):470-9. PubMed ID: 4480629
    [No Abstract]   [Full Text] [Related]  

  • 34. Prorenin as a reproductive hormone. New form of the renin system.
    Sealey JE; Glorioso N; Itskovitz J; Laragh JH
    Am J Med; 1986 Dec; 81(6):1041-6. PubMed ID: 3541589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of ovarian hyperstimulation syndrome by antihistamine.
    Gergely RZ; Paldi E; Erlik Y; Makler A
    Obstet Gynecol; 1976 Jan; 47(1):83-5. PubMed ID: 1697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The significance of the ovarian arteriolar vasodilatation in pathogenesis of the ovarian hyperstimulation syndrome].
    Vasiljević M; Prorocić M; Tasić L; Stanimirović B; Dikić S; Mandić V; Jeremić D
    Srp Arh Celok Lek; 2006; 134(7-8):344-7. PubMed ID: 17009617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mechanism of aldosterone response to furosemide test in patients with Shy-Drager syndrome.
    Sasaki K; Murabayashi S; Baba T; Aoyagi K; Matsunaga M; Takebe K; Nigawara K
    Horm Metab Res; 1983 Dec; 15(12):610-5. PubMed ID: 6363244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin.
    Tulandi T; McInnes RA; Arronet GH
    Int J Fertil; 1984; 29(2):113-7. PubMed ID: 6148315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma prolactin, human chorionic gonadotropin, estradiol, testosterone, and progesterone in the ovarian hyperstimulation syndrome.
    Yuen BH; McComb P; Sy L; Lewis J; Cannon W
    Am J Obstet Gynecol; 1979 Feb; 133(3):316-20. PubMed ID: 433993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the renin--aldosterone axis and of prolactin secretion during pregnancy by L-dopa.
    Kaulhausen H; Oney T; Leyendecker G
    Br J Obstet Gynaecol; 1982 Jun; 89(6):483-8. PubMed ID: 7044409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.